Croatian Cooperative Group For Hematologic Diseases
Croatian Cooperative Group For Hematologic Diseases is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with Brentuximab Vedotin-ESHAP vs ESHAP in Patients with Relapsed / Refractory Classical Hodgkin’s Lymphoma, Followed by Brentuximab Vedotin Consolidation (instead of Autologous Hematopoietic Stem Cell Transplantation) in Those who Attained a Metabolic Complete Remission after Salvage Therapy
Sponsor Fundacion Geltamo
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Croatian Cooperative Group For Hematologic Diseases?
The 2026-10-09 snapshot links Croatian Cooperative Group For Hematologic Diseases to 1 distinct CTIS trials. Recorded services include Clinical monitoring, Project management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Croatian Cooperative Group For Hematologic Diseases?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Croatian Cooperative Group For Hematologic Diseases conducted?
The linked trials record locations in 4 countries, including Austria, Spain, Greece, Croatia. These are trial locations, not confirmed office locations or countries where Croatian Cooperative Group For Hematologic Diseases delivered services.
What can this page tell me about Croatian Cooperative Group For Hematologic Diseases's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Croatian Cooperative Group For Hematologic Diseases. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Croatian Cooperative Group For Hematologic Diseases